EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock News

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

SHIRLEY, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) issued a press release on Monday, February...

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

SHIRLEY, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) has announced a significant reduction in...

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

SHIRLEY, N.Y., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) is pleased to announce that the Company’s...

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Launches Evome Medical Products Distribution Company, Appoints Bill Garbarini Chief Operating Officer Adding Plan for a broader portfolio of Life Science...

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today announced ‎the results...

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y.,...

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to...

Evome Medical Technologies Retains irlabs for Investor Relations Services

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered...

Evome Medical Technologies Announces Securities Issuances

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional...

Evome Medical Engages ICP Securities Inc. for Automated Market Making Services

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) --  Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT), is pleased to announce that it...

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary...

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

Posting Q1 Financials, Provides Updates on Strong Q2...

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the “Company” or “Evome”) highlighted the strengthening credit relationship...

Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) has reached an agreement with EB...

Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) announced today preliminary annual financial...

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) announces the appointment of two senior healthcare...

Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) has executed a non-binding letter of intent (LOI)...

Mentions: SGMD.CA

Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-Out

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the ‎‎‎“Company”) ‎‎‎(TSXV: EVMT) announced it has reduced acquisition bank...

Mentions: SGMD.CA